Fudosteine Impurity Q
|
福多司坦杂质Q
|
|
METHYL DESOXYCHOLATE
|
脱氧胆酸甲酯
|
3245-38-3
|
Moxifloxacin EP Imp.B
|
莫西沙星EP杂质B
|
1029364-73-5
|
N-[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine
|
达比加群酯杂质DBZI-IMP 1
|
212322-77-5
|
(R)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine
|
(R)-1-(3-乙氧基-4-甲氧基苯基)-2-(甲基磺酰基)乙胺
|
608142-27-4
|
ethyl 3-(1-methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate
|
达比加群酯杂质DBZI-IMP 2
|
1642853-67-5
|
4-(4-(3-(2-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide
|
甲苯磺酸索拉非尼杂质VI
|
1431697-81-2
|
5-Methyl-3-phenylisoxazole-4-carboxylic acid
|
苯唑西林杂质C
|
1136-45-4
|
Olopatadine Impurity 24
|
奥洛他定杂质24
|
4174-83-8
|
Phosphonium, [[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]me
|
瑞舒伐他汀钙SM1
|
885477-83-8
|
2-Amino-4-trifluoromethylbenzonitrile
|
2-氨基-4-三氟甲基苯腈
|
1483-54-1
|
cefmetazole
|
头孢美唑7位四氮唑
|
784228-11-8
|
N-DesMethyl Olopatadine
|
奥洛他定杂质42
|
113835-92-0
|
(Z)-ethyl 5-((5-fluoro-2-oxoindolin-3-ylidene)Methyl)-2,4-diMethyl-1H-pyrrole-3-carboxylate
|
苹果酸舒尼替尼P
|
1104253-05-5
|
Dabigatran Impurity F
|
达比加群酯杂质F
|
1610758-21-8
|
2,2'-METHYLIMINOBIS-(ACETALDEHYDE DIMETHYL ACETAL)
|
N-(2,2-甲氧基乙基)-2,2-甲氧基-N-甲基-乙胺
|
70887-96-6
|
(1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate
|
奥司他韦AS1杂质
|
204254-96-6
|
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate
|
尼达尼布杂质D
|
1987887-92-2
|
Moxifloxacin Related Compound A (HCl salt form)
|
莫西沙星杂质A(盐酸盐)
|
151282-23-4
|
6-Aminopenicillanic acid
|
阿莫西林杂质A
|
551-16-6
|
Vonoprazan Impurity 24
|
沃诺拉赞杂质24
|
1807642-41-6
|
Nintedanib Impurity 36
|
尼达尼布杂质36
|
2093243-16-2
|
Ethyl (3R,4R,5S)-5-N,N-diallylamino-4-(1,1-dimethylethyl)amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
|
奥司他韦AS4杂质
|
651324-06-0
|
Nintedanib Impurity
|
尼达尼布杂质40
|
78466-25-8
|
Nintedanib Impurity 18
|
尼达尼布杂质18
|
2514952-69-1
|
Cyproheptadine EP Impurity C
|
盐酸赛庚啶杂质C
|
3967-32-6
|
Vitamin B6 Impurity 1
|
乙氧基维生素B6杂质
|
765235-25-4
|
2,6-DiMethoxy-1,4-benzoquinone
|
2,6-二甲氧基-1,4-苯醌
|
530-55-2
|
4-Nitro-2-phenoxyaniline
|
尼美舒利杂质D
|
5422-92-4
|
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
|
达比加群酯杂质B
|
211914-50-0
|
Intedanib Impurity
|
尼达尼布杂质
|
894783-71-2
|
Dabigatran Impurity L
|
达比加群酯杂质L
|
1580491-16-2
|
Celecoxib 2-Methyl Analog
|
塞来昔布杂质C
|
170569-99-0
|
Dabigatran Impurity J
|
达比加群酯杂质J
|
1416446-45-1
|
Nintedanib-013-CO
|
尼达尼布杂质
|
2218446-42-3
|
(5S)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
|
左西孟旦M1杂质A
|
101328-84-1
|
diethyl 2-(3-methylbutylidene)propanedioate
|
2-(3-甲基丁烯基)丙二酸酯
|
51615-30-6
|
Propranolol EP Impurity A
|
盐酸普萘洛尔杂质A
|
36112-95-5
|
(3-methyl-6-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol
|
2-羟甲基-3-甲基-6-(2,2,2-三氟乙氧基)吡啶
|
|
Dabigatran Impurity 25
|
达比加群酯杂质DBZII-IMP 3
|
1643377-48-3
|
Dabigatran Impurity 9
|
达比加群酯杂质DBZII-IMP 2
|
1408238-41-4
|
Dibenz[b,f]azepine-5-carbonyl chloride
|
亚氨基芪甲酰氯对照品
|
33948-22-0
|
1-(naphthalen-2-yloxy)-3-[(propan-2-yl)amino]propan-2-ol
|
1-(异丙基氨基)-3-(萘-2-氧基)丙烷-2-醇
|
2007-72-9
|
2,2'-(piperazine-1,4-diyl)bis(N-(4-aminophenyl)-N-methylacetamide)
|
尼达尼布杂质10
|
2410284-89-6
|
2,6-DIMETHYLTHIOPHENOL
|
2,6-二甲基苯硫酚
|
118-72-9
|
Upadacitinib Impurity 23
|
乌帕替尼杂质G
|
2715120-86-6
|
Amisulpride EP Impurity D
|
氨磺必利杂质D
|
71676-00-1
|
Bortezomib Impurity M
|
硼替佐米杂质M
|
886979-81-3
|
Propranolol EP Impurity C
|
普萘洛尔杂质C
|
17216-10-3
|
Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity)
|
达比加群酯杂质H
|
1408238-36-7
|
S-Methyl Cefmetazole
|
甲疏基头孢美唑
|
68576-47-6
|
Methyl Chenodeoxycholate
|
鹅去氧胆酸甲酯
|
3057-04-3
|
4-Aminobenzamidine dihydrochloride
|
达比加群酯杂质DBZII-IMP 6
|
2498-50-2
|
5-Methyl-3-phenylisoxazole-4-carbonyl chloride
|
5-甲基-3-苯基-4-异唑甲酰氯
|
16883-16-2
|
1-(3-CHLOROMETHYL-4-HYDROXY-PHENYL)-ETHANONE
|
沙丁胺醇杂质13
|
24085-05-0
|
Nintedanib Impurity
|
(Z)-3-(((4-乙酰氨基苯基)氨基)(苯基)亚甲基)-2-氧代二氢吲哚-6-羧酸甲酯
|
1139458-48-2
|
(5-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol
|
2-羟甲基-5-甲基-4-(2,2,2-三氟乙氧基)吡啶
|
103577-73-7
|
Methyl Cholate
|
胆酸甲酯
|
1448-36-8
|
Rosuvastatin EP Impurity D
|
瑞舒伐他汀钙杂质D
|
503610-43-3
|
Dabigatran Impurity E
|
达比加群酯杂质E
|
212321-78-3
|
Dabigatran Impurity P
|
达比加群酯杂质P
|
1422435-41-3
|
Dabigatran Impurity A
|
达比加群酯杂质A
|
1408238-40-3
|
4-[(2R)-2-(3,4,5,6-tetrahydro-2H-pyran-2-yloxy)-propionyl]morpholine
|
艾氟康唑杂质34
|
135270-08-5
|
Sirolimus isomer C
|
西罗莫司异构体C
|
150821-39-9
|
Pentoxifylline Impurity 13
|
己酮可可碱杂质13
|
84321-40-4
|
Imatinib Impurity V
|
伊马替尼杂质V
|
571186-93-1
|
Dabigatran Impurity O
|
达比加群酯杂质O
|
1702936-92-2
|
Olopatadine Impurity 39
|
奥洛他定杂质39
|
111088-69-8
|
Ethyl (1R,5R,6R)-7-(tert-butyl)-5-(pentan-3-yloxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylate
|
奥司他韦AS3杂质
|
2417645-75-9
|
Butylphthalide Impurity
|
3-丁基-2-甲基异吲哚啉-1-酮
|
122654-49-3
|
Cefotaxime Impurity 7(Cefotaxime EP Impurity G)
|
头孢噻肟杂质G
|
2489535-06-8
|
Indometacin EP Impurity I
|
吲哚美辛EP杂质I
|
16401-99-3
|
Dabigatran Etexilate iMpurity O
|
达比加群酯杂质K
|
1349500-09-9
|
Bortezomib ImpurityN
|
硼替佐米杂质N
|
886979-78-8
|
Dabigatran Impurity 24
|
达比加群酯杂质DBZII-IMP 8
|
1456889-80-7
|
Indometacin EP Impurity E
|
吲哚美辛EP杂质E
|
807614-94-4
|
Dabigatran Impurity N
|
达比加群酯杂质N
|
1408238-37-8
|
Nintedanib impurity G
|
尼达尼布杂质G
|
894783-61-0
|
Nintedanib impurity
|
尼达尼布杂质
|
2410284-90-9
|
Bumetanide EP Impurity B
|
布美他尼EP杂质B
|
28328-54-3
|
Methyl 3,7-Di-O-acetylcholate
|
3,7-二-O-乙酰胆酸甲酯
|
3749-87-9
|
Nintedanib Impurity 2
|
尼达尼布杂质2
|
2653-15-8
|
Nintedanib Impurity 30
|
尼达尼布杂质30
|
1860012-61-8
|
4-AMINO-5,6-DICHLOROBENZENE-1,3-DISULFONAMIDE
|
4-氨基-5,6-二氯苯-1,3-二磺酰胺
|
5250-72-6
|
Dibenzosuberone
|
盐酸赛庚啶杂质B
|
1210-35-1
|
Nintedanib Impurity 30
|
尼达尼布杂质30
|
1038972-16-5
|
Methyl 1-acetyl-2-oxoindoline-6-carboxylate
|
1-乙酰基-2,3-二氢-2-氧代-1H-吲哚-6-羧酸甲酯
|
676326-36-6
|
TAUROURSODEOXYCHOLIC ACID SODIUM SALT
|
牛磺熊去氧胆酸钠
|
35807-85-3
|
Glyceryl triundecanoate
|
十一碳酸甘油三酯
|
13552-80-2
|
(trans)-4-(((trans)-4-(aminomethyl)cyclohexanecarboxamido)methyl) cyclohexanecarboxylic
|
氨甲环酸杂质E
|
82755-59-7
|
Intedanib Impurity
|
尼达尼布杂质
|
2243384-71-4
|
Nintedanib Impurity
|
尼达尼布杂质G
|
2410649-54-4
|
(3S,4R)-3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
|
乌帕替尼WPT-4
|
2411540-30-0
|
hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride
|
达比加群酯杂质I
|
1307233-93-7
|
Dabigatran Impurity G
|
达比加群酯杂质G
|
1610758-19-4
|
Dabigatran Impurity C
|
达比加群酯杂质C
|
1610758-20-7
|
Nintedanib Impurity 16
|
尼达尼布杂质 16
|
1438271-13-6
|
tert-butyl ((1S,2R,5R)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate
|
(1S,2R,5R)-2-氨基-5-[(二甲基氨基)羰基]环己基] 氨基甲酸叔丁酯
|
2089454-69-1
|
Cefpodoxime Proxetil EP Impurity A
|
头孢泊肟酯杂质A
|
80210-62-4
|
2-(Cyanomethylthio)acetic acid
|
2-(氰基甲硫基)乙酸
|
55817-29-3
|